# Castle Point Trans-Tasman Fund

> Mechanical fund record. Sourced from the FMA Disclose register. ManagedFundsNZ does not give financial advice and does not publish opinion-based ratings.

- **Manager:** Castle Point
- **Asset class:** Australasian Equities
- **Structure:** NZ Portfolio Investment Entity (PIE) — investor tax capped at PIR (max 28%)
- **Confidence tier:** C (Sorted Smart Investor → FMA Disclose)
- **Last verified:** 2026-05-22

## Summary

The Castle Point Trans-Tasman Fund is a australasian equities managed fund run by Castle Point. Wellington-based active manager with concentrated trans-Tasman and global multi-asset funds.

## Investment objective (from PDS)

> The Fund invests in New Zealand and Australian listed companies and is benchmarked to the S&P/NZX 50 Index (including imputation credits). The performance objective of the Fund is to outperform the benchmark over rolling five-year periods after all fees (and other expenses) but before tax.

Source: Product Disclosure Statement dated 2026-03-31 (Tier A, lodged on FMA Disclose register). https://smartinvestor.sorted.org.nz/disclose-document/ff7589b06dd9881f/2026-04-PDS---Trans-Tasman.pdf

## Fund data

- **Annual fund charge:** 1.08% p.a. (from the latest Quarterly Fund Update)
- **5-year return (after charges, after tax at 28% PIR):** 0.91% p.a.
- **Risk indicator:** 5/7 on the FMA-mandated standardised scale (1 = lower risk, 7 = higher risk)
- **Fund size (AUM):** NZ$12 million
- **Asset mix:** 98% growth assets · 2% income assets
- **Fund started:** 20 November 2018
- **Minimum initial investment:** NZ$10,000

## Top 10 holdings

1. Fisher & Paykel Healthcare Ltd — 16.03%
2. Infratil Ltd — 9.92%
3. Auckland International Airport Ltd — 9.71%
4. Contact Energy Ltd — 8.03%
5. A2 Milk Company Ltd — 5.77%
6. Meridian Energy Limited — 5.39%
7. Mainfreight Ltd — 4.61%
8. Mercury NZ Limited — 4.36%
9. Ebos Group Ltd — 2.97%
10. Spark New Zealand Ltd — 2.95%

Holdings are disclosed in every Quarterly Fund Update; the full portfolio holdings file is available via the FMA Disclose register.

## Additional terms (from PDS)

- **Minimum subsequent investment:** NZ$1,000
- **Distribution cadence:** quarterly
- **Buy / sell spread:** 15 bps / 15 bps (transaction cost on subscription / redemption)

## Investment policy (from SIPO)

### Strategic asset allocation ranges

| Asset class | Target | Min | Max |
| --- | ---: | ---: | ---: |
| Cash and cash equivalents | 2% | 0% | 10% |
| Australasian equities | 98% | 90% | 100% |
| New Zealand equities | — | 65% | 100% |
| Australian equities | — | 0% | 25% |
| Individual listed equity | — | 0% | — |

### Responsible-investment approach

ESG measures are incorporated into the research process via three approaches: positive screening (actively seeking investments with long-term positive ESG attributes), negative screening/blacklisting (excluding sectors, industries, companies and practices with materially negative ESG attributes), and research and engagement to understand historical or current issues and actions being taken. Castle Point is a founding signatory to the Stewardship Code Aotearoa New Zealand and a signatory to the UNPRI.

### Derivatives policy

Derivatives can only be used in accordance with the investment strategy of each fund for risk management, hedging (including currency), and implementing investment opportunities. A counterparty assessment and approval process is maintained and a list of approved counterparties is kept by the compliance team.

### Exclusions

- Sectors, industries, companies and practices with materially negative ESG attributes (as maintained on the blacklist by the Investment Committee)
- Unlisted equities
- Fixed interest
- Derivatives (tail risk/other)
- International (non-Australasian) equities

Source: Statement of Investment Policy and Objectives dated 2026-03-25. https://smartinvestor.sorted.org.nz/disclose-document/3c69ad15c9c3b276/SIPO---2026-03.pdf

## How to invest

Available via: Castle Point directly. Read the current Product Disclosure Statement (PDS) before investing.

## Sources

- **FMA Disclose register** (primary): https://disclose-register.companiesoffice.govt.nz/search?searchType=ALL&q=Castle%20Point%20Trans-Tasman%20Fund
- **Product Disclosure Statement:** /disclose-document/7785322a9542268e/2026-04-PDS---Ranger.pdf
- **Sorted Smart Investor** (cross-validation): https://smartinvestor.sorted.org.nz/kiwisaver-and-managed-funds/SCH10745/OFR10746/FND12482/
- **Manager website:** https://castlepoint.co.nz

## Citations (authoritative primary sources)

- FMA Disclose register — https://disclose-register.companiesoffice.govt.nz/ (publisher: Financial Markets Authority, NZ)
- Inland Revenue — PIE / PIR rules — https://www.ird.govt.nz/roles/portfolio-investment-entities
- Financial Markets Conduct Act 2013 — https://www.legislation.govt.nz/act/public/2013/0069/latest/DLM4090578.html
- Sorted Smart Investor (cross-validation only) — https://smartinvestor.sorted.org.nz/

## This file

- **Canonical HTML:** https://managedfunds.nz/funds/castle-point/trans-tasman/
- **Markdown (this file):** https://managedfunds.nz/funds/castle-point/trans-tasman/markdown.md
- **Structured data (JSON):** https://managedfunds.nz/funds/castle-point/trans-tasman/data.json
- **First published:** 2026-05-08
- **Last refreshed:** 2026-05-22
- **Reuse licence:** citation with link back to the canonical HTML is granted. No paid redistribution. Full terms: https://managedfunds.nz/llms-policy.txt

---

ManagedFundsNZ is independent. We are not a Financial Advice Provider. This page is general information sourced from the FMA Disclose register; it is not personalised financial advice. Read the current PDS and consider talking to a licensed adviser before investing.
